These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32373264)

  • 21. Measles outbreak investigation in an urban slum of Kaduna Metropolis, Kaduna State, Nigeria, March 2015.
    Babalola OJ; Ibrahim IN; Kusfa IU; Gidado S; Nguku P; Olayinka A; Abubakar A
    Pan Afr Med J; 2019; 32():150. PubMed ID: 31303921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria.
    Sato R
    Hum Vaccin Immunother; 2024 Dec; 20(1):2355036. PubMed ID: 38783606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priorities in global measles control: report of an outbreak in N'Djamena, Chad.
    Ndikuyeze A; Cook A; Cutts FT; Bennett S
    Epidemiol Infect; 1995 Oct; 115(2):309-14. PubMed ID: 7589270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad.
    Grais RF; Dubray C; Gerstl S; Guthmann JP; Djibo A; Nargaye KD; Coker J; Alberti KP; Cochet A; Ihekweazu C; Nathan N; Payne L; Porten K; Sauvageot D; Schimmer B; Fermon F; Burny ME; Hersh BS; Guerin PJ
    PLoS Med; 2007 Jan; 4(1):e16. PubMed ID: 17199407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descriptive epidemiology of measles surveillance data, Osun state, Nigeria, 2016-2018.
    Shorunke FO; Adeola-Musa O; Usman A; Ameh C; Waziri E; Adebowale SA
    BMC Public Health; 2019 Dec; 19(1):1636. PubMed ID: 31801513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008.
    Fiebelkorn AP; Redd SB; Gastañaduy PA; Clemmons N; Rota PA; Rota JS; Bellini WJ; Wallace GS
    J Pediatric Infect Dis Soc; 2017 Mar; 6(1):40-48. PubMed ID: 26666559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing epidemiology of measles in Hong Kong from 1961 to 1990--impact of a measles vaccination program.
    Lau YL; Chow CB; Leung TH
    J Infect Dis; 1992 Jun; 165(6):1111-5. PubMed ID: 1583329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Widespread outbreaks of measles in rural Uttar Pradesh, India, 1996: high risk areas and groups.
    Singh J; Kumar A; Rai RN; Khare S; Jain DC; Bhatia R; Datta KK
    Indian Pediatr; 1999 Mar; 36(3):249-56. PubMed ID: 10713838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress towards elimination of measles in Kenya, 2003-2016.
    Kisangau N; Sergon K; Ibrahim Y; Yonga F; Langat D; Nzunza R; Borus P; Galgalo T; Lowther SA
    Pan Afr Med J; 2018; 31():65. PubMed ID: 31007812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles outbreak response immunization during the COVID-19 pandemic: lessons from Borno State, Nigeria.
    Nomhwange T; Mohammed A; Jean Baptiste AE; Musa A; Yusuf A; Yusuf M; Wagai J; Shettima A; Meleh S; Banda R; Braka F; Luce R; Masresha B
    Pan Afr Med J; 2022; 41():104. PubMed ID: 35432705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The measles outbreak in Bulgaria, 2009-2011: An epidemiological assessment and lessons learnt.
    Muscat M; Marinova L; Mankertz A; Gatcheva N; Mihneva Z; Santibanez S; Kunchev A; Filipova R; Kojouharova M
    Euro Surveill; 2016; 21(9):30152. PubMed ID: 26967661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Internal displacement; an impediment to the successful implementation of planned measles supplemental activities in Nigeria, a case study of Benue State.
    Korave J; Bawa S; Ageda B; Ucho A; Bem-Bura DM; Onimisi A; Dieng B; Nsubuga P; Oteri J; Fiona B; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C76-C81. PubMed ID: 33461836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing trends in measles vaccination status between 2004 and 2014 among children aged 12-23 months in Bangladesh.
    Jahan Y; Moriyama M; Rahman MM; Shahid ASMSB; Rahman A; Hossain N; Das SK; Hossain MI; Golam Faruque AS; Chisti MJ
    Trop Med Int Health; 2020 Apr; 25(4):475-482. PubMed ID: 31863611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two outbreaks of measles in Germany 2005.
    Siedler A; Tischer A; Mankertz A; Santibanez S
    Euro Surveill; 2006; 11(4):131-4. PubMed ID: 16645244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles mortality and vaccine efficacy in rural West Africa.
    Hull HF; Williams PJ; Oldfield F
    Lancet; 1983 Apr; 1(8331):972-5. PubMed ID: 6132278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Madagascar 2018-2019 measles outbreak response: main strategic areas.
    Sodjinou VD; Douba A; Nimpa MM; Masembe YV; Randria M; Ndiaye CF
    Pan Afr Med J; 2020; 37():20. PubMed ID: 33062122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.